We believe in the power of science—and our people—to make the seemingly impossible possible.
Our external collaborations and investments aim to propel discovery in cancer treatment and complement our areas of concentration.
We are committed to pursuing a diverse and purposeful pipeline that investigates drivers of treatment resistance and tumor progression.
Investigating an oncogenic pathways inhibitor in metastatic colorectal cancer
Investigating a WT1 cancer vaccine in recurrent or progressive glioblastoma
Investigating a CDK9inhibitor in myelodysplastic syndromes
If you have a passion for making a meaningful difference in the lives of patients and the community, we already have something in common.